Effect of Ishige okamurae extract on musculoskeletal biomarkers in adults with relative sarcopenia: Study protocol for a randomized double-blind placebo-controlled trial

IntroductionSarcopenia is a phenomenon in which skeletal muscle mass decreases with age, causing many health problems. Many studies have been conducted to improve sarcopenia nutritionally. Ishige okamura (IO) is a genus of brown algae and plays a role in anti-diabetes, anti-obesity, and myogenesis....

Full description

Bibliographic Details
Main Authors: Sae Rom Lee, Ye Li Lee, Sang Yeoup Lee
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Nutrition
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2022.1015351/full
_version_ 1798001411052535808
author Sae Rom Lee
Ye Li Lee
Sang Yeoup Lee
Sang Yeoup Lee
Sang Yeoup Lee
author_facet Sae Rom Lee
Ye Li Lee
Sang Yeoup Lee
Sang Yeoup Lee
Sang Yeoup Lee
author_sort Sae Rom Lee
collection DOAJ
description IntroductionSarcopenia is a phenomenon in which skeletal muscle mass decreases with age, causing many health problems. Many studies have been conducted to improve sarcopenia nutritionally. Ishige okamura (IO) is a genus of brown algae and plays a role in anti-diabetes, anti-obesity, and myogenesis. However, the effect of IO extract (IOE) on human muscle strength and mass is unclear. Therefore, we will examine the impact and safety of consumption of IOE for 12 weeks on muscle strength and mass in middle-aged and old-aged adults with relatively low skeletal muscle mass.Materials and methodsA randomized controlled trial is conducted on 80 adults aged 50–80. A total of 80 participants will be enrolled in this study. Participants assign IOE-taking group (n = 40) and placebo taking group (n = 40). At a baseline and 12 weeks after treatment, the following parameters of the participants are checked: knee extension strength, handgrip strength, body composition, laboratory tests, dietary recall, physical activity, and EQ-5D-5L.DiscussionThe present study will be the first randomized, double-blind placebo-controlled trial to examine the efficacy and tolerability of IOE supplementation in adults with relatively low muscle mass. The nutritional intake and physical activity that might influence muscle strength and mass will be considered as covariates for transparency of results. The results of this study will provide clinical evidence for sarcopenia patients with nutrient treatment.Clinical Trial Registrationwww.clinicaltrials.gov/, Identifier: NCT04617951.
first_indexed 2024-04-11T11:35:53Z
format Article
id doaj.art-80513184e08349d3a284d5cdd1ff9ec9
institution Directory Open Access Journal
issn 2296-861X
language English
last_indexed 2024-04-11T11:35:53Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nutrition
spelling doaj.art-80513184e08349d3a284d5cdd1ff9ec92022-12-22T04:25:58ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2022-09-01910.3389/fnut.2022.10153511015351Effect of Ishige okamurae extract on musculoskeletal biomarkers in adults with relative sarcopenia: Study protocol for a randomized double-blind placebo-controlled trialSae Rom Lee0Ye Li Lee1Sang Yeoup Lee2Sang Yeoup Lee3Sang Yeoup Lee4Family Medicine Clinic and Biomedical Research Institute, Pusan National University Yangsan Hospital, Yangsan, South KoreaIntegrated Research Institute for Natural Ingredients and Functional Foods, Yangsan, South KoreaFamily Medicine Clinic and Biomedical Research Institute, Pusan National University Yangsan Hospital, Yangsan, South KoreaIntegrated Research Institute for Natural Ingredients and Functional Foods, Yangsan, South KoreaDepartment of Medical Education, Pusan National University School of Medicine, Yangsan, South KoreaIntroductionSarcopenia is a phenomenon in which skeletal muscle mass decreases with age, causing many health problems. Many studies have been conducted to improve sarcopenia nutritionally. Ishige okamura (IO) is a genus of brown algae and plays a role in anti-diabetes, anti-obesity, and myogenesis. However, the effect of IO extract (IOE) on human muscle strength and mass is unclear. Therefore, we will examine the impact and safety of consumption of IOE for 12 weeks on muscle strength and mass in middle-aged and old-aged adults with relatively low skeletal muscle mass.Materials and methodsA randomized controlled trial is conducted on 80 adults aged 50–80. A total of 80 participants will be enrolled in this study. Participants assign IOE-taking group (n = 40) and placebo taking group (n = 40). At a baseline and 12 weeks after treatment, the following parameters of the participants are checked: knee extension strength, handgrip strength, body composition, laboratory tests, dietary recall, physical activity, and EQ-5D-5L.DiscussionThe present study will be the first randomized, double-blind placebo-controlled trial to examine the efficacy and tolerability of IOE supplementation in adults with relatively low muscle mass. The nutritional intake and physical activity that might influence muscle strength and mass will be considered as covariates for transparency of results. The results of this study will provide clinical evidence for sarcopenia patients with nutrient treatment.Clinical Trial Registrationwww.clinicaltrials.gov/, Identifier: NCT04617951.https://www.frontiersin.org/articles/10.3389/fnut.2022.1015351/fulldietary supplementssarcopeniaIshige okamuraemusclerandomized clinical trialadult
spellingShingle Sae Rom Lee
Ye Li Lee
Sang Yeoup Lee
Sang Yeoup Lee
Sang Yeoup Lee
Effect of Ishige okamurae extract on musculoskeletal biomarkers in adults with relative sarcopenia: Study protocol for a randomized double-blind placebo-controlled trial
Frontiers in Nutrition
dietary supplements
sarcopenia
Ishige okamurae
muscle
randomized clinical trial
adult
title Effect of Ishige okamurae extract on musculoskeletal biomarkers in adults with relative sarcopenia: Study protocol for a randomized double-blind placebo-controlled trial
title_full Effect of Ishige okamurae extract on musculoskeletal biomarkers in adults with relative sarcopenia: Study protocol for a randomized double-blind placebo-controlled trial
title_fullStr Effect of Ishige okamurae extract on musculoskeletal biomarkers in adults with relative sarcopenia: Study protocol for a randomized double-blind placebo-controlled trial
title_full_unstemmed Effect of Ishige okamurae extract on musculoskeletal biomarkers in adults with relative sarcopenia: Study protocol for a randomized double-blind placebo-controlled trial
title_short Effect of Ishige okamurae extract on musculoskeletal biomarkers in adults with relative sarcopenia: Study protocol for a randomized double-blind placebo-controlled trial
title_sort effect of ishige okamurae extract on musculoskeletal biomarkers in adults with relative sarcopenia study protocol for a randomized double blind placebo controlled trial
topic dietary supplements
sarcopenia
Ishige okamurae
muscle
randomized clinical trial
adult
url https://www.frontiersin.org/articles/10.3389/fnut.2022.1015351/full
work_keys_str_mv AT saeromlee effectofishigeokamuraeextractonmusculoskeletalbiomarkersinadultswithrelativesarcopeniastudyprotocolforarandomizeddoubleblindplacebocontrolledtrial
AT yelilee effectofishigeokamuraeextractonmusculoskeletalbiomarkersinadultswithrelativesarcopeniastudyprotocolforarandomizeddoubleblindplacebocontrolledtrial
AT sangyeouplee effectofishigeokamuraeextractonmusculoskeletalbiomarkersinadultswithrelativesarcopeniastudyprotocolforarandomizeddoubleblindplacebocontrolledtrial
AT sangyeouplee effectofishigeokamuraeextractonmusculoskeletalbiomarkersinadultswithrelativesarcopeniastudyprotocolforarandomizeddoubleblindplacebocontrolledtrial
AT sangyeouplee effectofishigeokamuraeextractonmusculoskeletalbiomarkersinadultswithrelativesarcopeniastudyprotocolforarandomizeddoubleblindplacebocontrolledtrial